Earnings Feed
Start Free
Home/Filings/4/0002055011-26-000003
4//SEC Filing

Imam Tariq 4

Accession 0002055011-26-000003

CIK 0000320017other
View on SEC.govCompany Profile

Filed

Jan 12, 7:00 PM ET

Accepted

Jan 13, 4:08 PM ET

Size

13.6 KB

Accession

0002055011-26-000003

Insider Transaction Report

Form 4
Period: 2026-01-09
LISATA THERAPEUTICS, INC.LSTA
Imam Tariq
SVP, Bus Dev, General Counsel
Transactions
  • Award

    Common Stock

    [F1][F2]
    2026-01-09+15,000→ 39,579 total
  • Tax Payment

    Common Stock

    [F3][F2]
    2026-01-09$1.97/sh−1,401$2,760→ 38,178 total
  • Tax Payment

    Common Stock

    [F3][F2]
    2026-01-09$1.97/sh−840$1,655→ 37,338 total
  • Tax Payment

    Common Stock

    [F3][F2]
    2026-01-09$1.97/sh−747$1,472→ 36,591 total
  • Tax Payment

    Common Stock

    [F3][F2]
    2026-01-09$1.97/sh−513$1,011→ 36,078 total
  • Award

    Stock Option (Right to Buy)

    [F4]
    2026-01-09+7,000→ 7,000 total
    Exercise: $1.97From: 2026-01-09Exp: 2036-01-09→ Common Stock (7,000 underlying)
Footnotes (4)
  • [F1]Represents 15,000 restricted stock awards granted under the Issuer's 2018 Equity Incentive Compensation Plan. The restricted stock awards vest in four equal installments, with one-fourth of the shares vesting on the date of grant and an additional one-fourth vesting on each of the first, second and third annual anniversaries of the grant date.
  • [F2]Includes 17,750 unvested restricted stock.
  • [F3]Shares withheld as payment of a tax liability on vesting of restricted stock.
  • [F4]One-fourth of the shares underlying the stock options vest immediately on the grant date, with an additional one-fourth vesting on each of the first, second and third anniversaries of the grant date.
Signature
Tariq Imam|2026-01-13

Documents

1 file

Issuer

LISATA THERAPEUTICS, INC.

CIK 0000320017

→
Entity typeother

Related Parties

1
  • filerCIK 0002055011

Filing Metadata

Form type
4
Filed
Jan 12, 7:00 PM ET
Accepted
Jan 13, 4:08 PM ET
Size
13.6 KB
View on SEC.gov